Office of the Vice President for Research


MediSynergics logo

Drug discovery process

MediSynergics, LLC is an early-stage pharmaceutical research company that is working on the discovery of new treatments for patients with inadequate or unmet medical needs.  The primary mission of the company to discover new chemical entities (NCE’s) for the treatment of human diseases.   The company has discovered several “hits” in the central nervous system CNS), infectious diseases (ID) and cancer therapeutics areas and have filed provisional and non-provisional patent applications with the US Patent and Trademark Office.  Most importantly MediSynergics was awarded a two-year grant ($600K) by the NIAID division of the National Institutes for Health to fund their antiparasitic project.


Dennis Godek, Co-Founder

Harry Howard, Co-Founder